Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Vincenzo Mettivier"'
Autor:
Ursula Sessa, Maria Celentano, Stefano Rocco, Rossella Fabbricini, Olimpia Finizio, Vincenzo Mettivier
Publikováno v:
Clinical Management Issues, Vol 6, Iss 2S, Pp 11-14 (2015)
Here we describe a case of a man with chronic myeloid leukemia at intermediate risk, according to the Sokal index. After cytoreduction with hydroxyurea, the patient started nilotinib at standard dose (600 mg/day) obtaining a complete haematological r
Externí odkaz:
https://doaj.org/article/52a2341672a54f938c2de15a524c96e6
Autor:
Antonella Vitale, Anna Guarini, Cristina Ariola, Giovanna Meloni, Omar Perbellini, Michele Pizzuti, Cinzia De Gregoris, Vincenzo Mettivier, Alessandro Pastorini, Giovanni Pizzolo, Marco Vignetti, Franco Mandelli, Robin Foà
Publikováno v:
Haematologica, Vol 92, Iss 3 (2007)
Background and Objectives The prognostic value of myeloid antigen (MyAg) expression in adult acute lymphoblastic leukemia (ALL) is still controversial. The aim of this study was to correlate the expression of MyAg with clinical, hematologic and biolo
Externí odkaz:
https://doaj.org/article/1356db971cfc489391fd4140992257d1
Autor:
Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Luca Dozza, Monica Galli, Francesco Di Raimondo, Claudia Crippa, Mario Boccadoro, Simona Barbato, Patrizia Tosi, Franco Narni, Vittorio Montefusco, Nicoletta Testoni, Antonio Spadano, Carolina Terragna, Norbert Pescosta, Giulia Marzocchi, Claudia Cellini, Piero Galieni, Sonia Ronconi, Marco Gobbi, Lucio Catalano, Antonio Lazzaro, Giovanni De Sabbata, Clotilde Cangialosi, Fabrizio Ciambelli, Pellegrino Musto, Francesca Elice, Michele Cavo, Renato Fanin, Roberto Foa', Alessandro Rambaldi, Giuseppe Rossi, Pietro Leoni, Paolo Corradini, Giuseppe Torelli, Giuseppe Fioritoni, Sergio Cortelazzo, Giorgio Lambertenghi Deliliers, Giorgio La Nasa, Alfonso Zaccaria, Paolo De Fabritiis, Nicola Cascavilla, Alberto Bosi, Gianpietro Semenzato, Luigi Gugliotta, Filippo Gherlinzoni, Emanuele Angelucci, Massimo Fabrizio Martelli, Maria Concetta Petti, Giuseppe Leone, Angelo Michele Carella, Fabio Ciceri, Armando Santoro, Felicetto Ferrara, Francesco Nobile, Alfonso Maria D'Arco, Alessandro Levis, Luciano Guardigni, Andrea Gallamini, Pier Paolo Fattori, Sergio Morandi, Dino Amadori, Bruno Rotoli, Salvatore Mirto, Giorgio Paladini, Ruggero Mozzana, Graziella Pinotti, Francesco Rodeghiero, Nicola Cantore, Vincenzo Pavone, Enrico Maria Pogliani, Anna Marina Liberati, Ignazio Majolino, Sergio Amadori, Francesco Lauria, Massimo Aglietta, Giovanni Quarta, Sergio Storti, Fortunato Morabito, Silvana Franca Capalbo, Alessandro Massimo Gianni, Vincenzo Mettivier, Vittorio Rizzoli, Carlo Bernasconi, Giuseppe Visani, Michele Pizzuti, Giacinto La Verde, Giuseppe Avvisati, Maurizio Longinotti, Eugenio Gallo, Franco Dammacco, Domenico Russo, Andrea Bacigalupo, Caterina Musolino
Publikováno v:
The Lancet Haematology. 7:e861-e873
Background: The phase 3 GIMEMA-MMY-3006 trial, which compared bortezomib, thalidomide, and dexamethasone (VTD) combination therapy with thalidomide and dexamethasone (TD) as induction therapy before and consolidation therapy after double autologous h
Autor:
Rossella Fabbricini, Ursula Sessa, Vincenzo Mettivier, Olimpia Finizio, Stefano Rocco, Maria Celentano
Publikováno v:
Clinical Management Issues, Vol 6, Iss 2S, Pp 11-14 (2015)
Here we describe a case of a man with chronic myeloid leukemia at intermediate risk, according to the Sokal index. After cytoreduction with hydroxyurea, the patient started nilotinib at standard dose (600 mg/day) obtaining a complete haematological r
Autor:
Maurizio Montella, Francesco Izzo, Domenico Ronga, Ferdinando Frigeri, Vincenzo Mettivier, Mario Tamburini, Anna Crispo, Giovanna de Bellis, Oreste Cuomo, Orlando Antonio Spada
Publikováno v:
Liver. 21:335-341
Background/Aims: HCV is a RNA virus that cannot be integrated with the host genome; it can, however, exert its oncogenic potential indirectly by contributing to the modulatory effects of the host immune system, probably through a capacity to elude th
Autor:
Vincenzo Mettivier, Mariarosaria De Marco, Ferdinando Frigeri, Anna Crispo, Mario Tamburini, Domenico Ronga, Gabriella Fabbrocini, Orlando Antonio Spada, Vincenzo Tridente, Maurizio Montella
Publikováno v:
Leukemia Research. 25:775-781
Hepatitis C virus (HCV) is a RNA virus that cannot be integrated with the host genome; it can, however, exert its oncogenetic potential indirectly by contributing to the modulator effects of the host immune system, probably through a capacity to elud
Autor:
Felicetto Ferrara, Giuseppina Mele, Renato Cimino, Vincenzo Mettivier, Vincenzo Rametta, Iolanda Antinolfi
Publikováno v:
American Journal of Hematology. 41:45-49
Forty-five patients suffering from advanced B-CLL were randomized to receive interferon-alpha (IFN alpha) or no treatment after achieving complete remission or partial response, following a chemotherapy protocol called MiNa. The two groups were fully
Publikováno v:
Leukemia & Lymphoma. 7:4-7
27 patients aged over 60 years with acute myelogenous leukemia (AML) were treated with a chemotherapy regimen consisting of a combination of idarubicin (IDA) and cytosine arabinoside (ARA-C) as the induction regimen, with etoposide and 6-thioguanine
Autor:
Carlo De Rosa, Giuseppina Mele, Vincenzo Rametta, Felicetto Ferrara, Olimpia Finizio, Luigi Del Vecchio, Vincenzo Mettivier, Orlando Antonio Spada
Publikováno v:
Leukemia & Lymphoma. 3:217-222
In a series of 107 patients suffering from acute myeloid leukemia (AML), blast cells from six patients were found to simultaneously express CD2 and CD7 antigens along with CD13, CD33, and CDw 65 in various combinations. The frequency of the expressio
Autor:
Robin Foà, Omar Perbellini, Cristina Ariola, Michele Pizzuti, Alessandro Pastorini, Marco Vignetti, Giovanna Meloni, Anna Guarini, Antonella Vitale, Giovanni Pizzolo, Cinzia De Gregoris, Vincenzo Mettivier, Franco Mandelli
Publikováno v:
Haematologica. 92(3)
Background and Objectives The prognostic value of myeloid antigen (MyAg) expression in adult acute lymphoblastic leukemia (ALL) is still controversial. The aim of this study was to correlate the expression of MyAg with clinical, hematologic and biolo